Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. organics analysis
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books

Refine by
Date

  • Older

Organics Analysis Articles & Analysis: Older

8 news found

Alfa Chemistry Now Offers Pharmaceutical and Drug Standards for Drug Discovery

Alfa Chemistry Now Offers Pharmaceutical and Drug Standards for Drug Discovery

Uniquely positioned to be a dedicated player in the analytical testing industry, Alfa Chemistry supplies a full range of analytical reagents. Today it announces to add pharmaceutical and drug standards to its already rich offering of chromatography standards. After this move, researchers can now easily have access to certified reference materials, environmental standards, food & beverage ...

ByAlfa Chemistry


Focal Healthcare and CIMTEC Sign Licensing Agreement for a Suite of 3D Ultrasound AI-Based Technologies

Focal Healthcare and CIMTEC Sign Licensing Agreement for a Suite of 3D Ultrasound AI-Based Technologies

The technology will be used at the patient’s bedside to image joints, organs and blood vessels. The product will offer advantages of being small, portable and affordable and conduct non-invasive and rapid 3D ultrasound imaging in any point of care setting. The system is enhanced with leading AI-driven organ-specific analysis targeted for a ...

ByFocal Healthcare


Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative agreement in a bid to advance analytical capabilities and drive innovation across the biopharmaceutical industry in areas including personalized medicine, monoclonal antibodies and gene and cell ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


DiamiR Announces Oral Presentation at 21st International Conference on Alzheimer`s Drug Discovery

DiamiR Announces Oral Presentation at 21st International Conference on Alzheimer`s Drug Discovery

About DiamiR DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient stratification, as well as disease progression and treatment monitoring. ...

ByDiamiR


DiamiR Receives USPTO Notice of Allowance For Key Patent Covering the Use of Circulating Brain-Enriched microRNA Biomarkers for Monitoring of Brain Aging; Provides Update on Its Patent Portfolio

DiamiR Receives USPTO Notice of Allowance For Key Patent Covering the Use of Circulating Brain-Enriched microRNA Biomarkers for Monitoring of Brain Aging; Provides Update on Its Patent Portfolio

The patent covers the use of methods developed by DiamiR based on targeted quantitative analysis of microRNAs enriched in the brain and detectable in blood plasma as biomarkers of brain aging. ...

ByDiamiR


DiamiR Receives Award from Alzheimer`s Drug Discovery Foundation to Accelerate Development of microRNA Biomarkers for Alzheimer`s Disease

DiamiR Receives Award from Alzheimer`s Drug Discovery Foundation to Accelerate Development of microRNA Biomarkers for Alzheimer`s Disease

About DiamiR DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient stratification, as well as disease progression and treatment monitoring. ...

ByDiamiR


DiamiR Announces Additional $345,000 Funding from the NIH for Development of CogniMIR

DiamiR Announces Additional $345,000 Funding from the NIH for Development of CogniMIR

About DiamiR DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma and is being developed for screening, patient stratification, as well as disease progression and treatment monitoring. ...

ByDiamiR


Demand for Tessella’s Analytics Partnership confirms IDC analytics forecast

Demand for Tessella’s Analytics Partnership confirms IDC analytics forecast

Tessella’s managed service for analytics, Tessella Analytics Partnership has welcomed five new blue chip customers in the last few months with consumer industries and life sciences enterprises particularly well represented. In May this year, IDC forecast that worldwide revenues for big data and business analytics will grow from nearly $122 billion in 2015 to $187 billion in 2019 in its ...

ByTessella Support Services plc

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT